Aleksic Maja, Pease Camilla K, Basketter David A, Panico Maria, Morris Howard R, Dell Anne
Division of Molecular Biosciences, Imperial College, London SW7 2AZ, UK.
Toxicol In Vitro. 2008 Aug;22(5):1169-76. doi: 10.1016/j.tiv.2008.03.006. Epub 2008 Mar 16.
A large proportion of allergic skin reactions are considered to be the result of skin exposure to small organic chemicals that possess the intrinsic ability to covalently modify skin proteins, either directly or following activation. In the absence of information about specific skin protein targets, studies of chemical modifications are limited to the use of model proteins. We have previously demonstrated that selected well known skin sensitizers (2,4-dinitro-1-chlorobenzene and phenyl salicylate) have the ability to covalently modify residues selectively on the model protein, human serum albumin. In the present work, we focus on the differences in covalent binding observed for two additional model proteins, human cytokeratin 14 and human cofilin, both constituent proteins of skin. Using matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) and nano LC-MS and -MS/MS strategies, the amino acid residues targeted by 2,4-dinitro-1-chlorobenzene on the two model proteins have been identified. In contrast, a structurally related non-sensitiser (2,4-dichloro-1-nitrobenzene) and a non-sensitising irritant (benzalkonium chloride) did not covalently modify the model proteins. Detailed examination of the results for the sensitizers indicate that reactive chemicals target nucleophilic amino acids residing in specific microenvironments of the 3D protein structure that are conducive to reactivity. This observation has important implications for the development of hapten-peptide binding assays. It is envisaged that the data from such assays will be integrated with outputs from other in vitro assays in the future to give a prediction of the sensitisation potential of novel chemicals.
很大一部分过敏性皮肤反应被认为是皮肤接触小分子有机化学物质所致,这些化学物质具有直接或经激活后共价修饰皮肤蛋白质的内在能力。在缺乏关于特定皮肤蛋白靶点信息的情况下,化学修饰研究仅限于使用模型蛋白。我们之前已证明,选定的知名皮肤致敏剂(2,4-二硝基-1-氯苯和水杨酸苯酯)能够在模型蛋白人血清白蛋白上选择性地共价修饰残基。在本研究中,我们聚焦于另外两种皮肤组成蛋白——人细胞角蛋白14和人丝切蛋白这两种模型蛋白上观察到的共价结合差异。使用基质辅助激光解吸/电离质谱(MALDI-MS)以及纳升液相色谱-质谱联用(nano LC-MS)和串联质谱(MS/MS)策略,已鉴定出2,4-二硝基-1-氯苯在这两种模型蛋白上靶向的氨基酸残基。相比之下,一种结构相关的非致敏剂(2,4-二氯-1-硝基苯)和一种无致敏性的刺激物(苯扎氯铵)并未共价修饰这些模型蛋白。对致敏剂结果的详细检查表明,活性化学物质靶向位于三维蛋白质结构特定微环境中有利于反应性的亲核氨基酸。这一观察结果对半抗原-肽结合测定的发展具有重要意义。预计此类测定的数据未来将与其他体外测定的结果整合,以预测新型化学物质的致敏潜力。